Stuart Weiss

7.3k total citations · 2 hit papers
28 papers, 5.8k citations indexed

About

Stuart Weiss is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Stuart Weiss has authored 28 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Oncology. Recurrent topics in Stuart Weiss's work include Lipoproteins and Cardiovascular Health (14 papers), Pharmaceutical Economics and Policy (6 papers) and Bone health and treatments (5 papers). Stuart Weiss is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Pharmaceutical Economics and Policy (6 papers) and Bone health and treatments (5 papers). Stuart Weiss collaborates with scholars based in United States, Austria and Chile. Stuart Weiss's co-authors include Antonio Lombardi, Norman H. Bell, Robert W. Downs, Robert R. Recker, Jose Adolfo Rodriguez-Portales, Uri Liberman, Laurence Hirsch, David Karpf, Hui Quan and Thomas Capizzi and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Stuart Weiss

28 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1995 1.8k citations Uri Liberman, Stuart Weiss et al. New England Journal of Medicine profile →
Alendronate for the Treatment of Osteoporosis in Men

2000 689 citations Eric Orwoll, Mark P. Ettinger et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Weiss United States	22	2.3k	2.0k	1.9k	1.3k	1.3k	28	5.8k
Vincenzo Lo Cascio Italy	41	800 0.3×	1.0k 0.5×	528 0.3×	1.0k 0.8×	588 0.5×	120	4.6k
Yan Gong United States	39	249 0.1×	593 0.3×	695 0.4×	1.3k 1.0×	1.4k 1.1×	200	4.9k
T. Scherstén Sweden	44	179 0.1×	841 0.4×	2.0k 1.1×	1.3k 1.0×	618 0.5×	247	6.5k
Hubert Scharnagl Austria	49	149 0.1×	378 0.2×	2.6k 1.4×	1.4k 1.1×	1.8k 1.4×	265	7.4k
Jane Armitage United Kingdom	31	215 0.1×	190 0.1×	2.6k 1.4×	807 0.6×	1.2k 0.9×	92	5.7k
Christiane Drechsler Germany	42	408 0.2×	155 0.1×	1.2k 0.6×	554 0.4×	1.3k 1.0×	124	5.3k
José Manuel Valdivielso Spain	39	192 0.1×	335 0.2×	832 0.4×	1.2k 1.0×	793 0.6×	181	6.0k
Keijiro Saku Japan	43	122 0.1×	340 0.2×	2.3k 1.2×	2.2k 1.7×	1.8k 1.4×	422	8.0k
Ioanna Gouni‐Berthold Germany	37	94 0.0×	234 0.1×	4.1k 2.2×	1.2k 0.9×	1.8k 1.4×	156	7.5k
Mahmut İlker Yılmaz Türkiye	48	113 0.0×	628 0.3×	968 0.5×	921 0.7×	959 0.7×	151	6.3k

Countries citing papers authored by Stuart Weiss

Since Specialization

Citations

This map shows the geographic impact of Stuart Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Weiss more than expected).

Fields of papers citing papers by Stuart Weiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Weiss. The network helps show where Stuart Weiss may publish in the future.

Co-authorship network of co-authors of Stuart Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Weiss. A scholar is included among the top collaborators of Stuart Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Weiss. Stuart Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Isaacsohn, Jonathan L., Donald B. Hunninghake, Helmut G. Schrott, et al.. (2003). Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia. Clinical Cardiology. 26(1). 18–24. 21 indexed citations

Hunninghake, Donald B., Mark E. McGovern, Michael J. Koren, et al.. (2003). A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin. Clinical Cardiology. 26(3). 112–118. 45 indexed citations

Ettinger, Mark P., Thomas Littlejohn, Sherwyn Schwartz, et al.. (2003). Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.. PubMed. 289(14). 1826–32. 151 indexed citations

Bays, Harold, Stuart Weiss, Claude Gagné, et al.. (2002). Ezetimibe added to ongoing statin therapy for treatment of primary hypercholesterolemia. Journal of the American College of Cardiology. 39. 245–245. 9 indexed citations

Gagné, Claude, Harold Bays, Stuart Weiss, et al.. (2002). Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. The American Journal of Cardiology. 90(10). 1084–1091. 389 indexed citations

Davidson, Michael H., Phillip D. Toth, Stuart Weiss, et al.. (2001). Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia. Clinical Cardiology. 24(6). 467–474. 81 indexed citations

Orwoll, Eric, Mark P. Ettinger, Stuart Weiss, et al.. (2000). Alendronate for the Treatment of Osteoporosis in Men. New England Journal of Medicine. 343(9). 604–610. 689 indexed citations breakdown →

Ravn, Pernille, Stuart Weiss, Jose Adolfo Rodriguez-Portales, et al.. (2000). Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal¹. The Journal of Clinical Endocrinology & Metabolism. 85(4). 1492–1497. 84 indexed citations

Davidson, Michael H., Maureen Dillon, Bruce R. Gordon, et al.. (1999). Colesevelam Hydrochloride (Cholestagel). Archives of Internal Medicine. 159(16). 1893–1893. 245 indexed citations

10.

Genant, Harry K., Johna Lucas, Stuart Weiss, et al.. (1998). Low-Dose Esterified Estrogen Therapy. Obstetrical & Gynecological Survey. 53(6). 363–364. 2 indexed citations

11.

Koren, Michael, Dean G. Smith, Michael H. Davidson, et al.. (1998). The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients. PharmacoEconomics. 14(1). 59–70. 51 indexed citations

12.

Kelley, David E., Zachary R. Freedman, Burritt Haag, et al.. (1998). Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care. 21(12). 2056–2061. 136 indexed citations

13.

McKenney, James M., L. McCormick, Stuart Weiss, et al.. (1998). A Randomized Trial of the Effects of Atorvastatin and Niacin in Patients with Combined Hyperlipidemia or Isolated Hypertriglyceridemia. The American Journal of Medicine. 104(2). 137–143. 64 indexed citations

14.

Stein, Evan A., Michael H. Davidson, Adrian S. Dobs, et al.. (1998). Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients. The American Journal of Cardiology. 82(3). 311–316. 56 indexed citations

15.

Davidson, Michael H., Stuart Weiss, Sherwyn Schwartz, et al.. (1997). Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals. The American Journal of Cardiology. 80(3). 347–348. 18 indexed citations

16.

Davidson, Michael, Stuart Weiss, R. Knopp, et al.. (1997). The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day. The American Journal of Cardiology. 79(1). 38–42. 146 indexed citations

17.

Liberman, Uri, Stuart Weiss, H. W. Minne, et al.. (1996). Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis. Obstetrical & Gynecological Survey. 51(4). 238–241. 62 indexed citations

18.

Heinonen, Therèse, Evan A. Stein, Stuart Weiss, et al.. (1996). The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study. Clinical Therapeutics. 18(5). 853–863. 41 indexed citations

19.

Nawrocki, J.W., Stuart Weiss, Michael H. Davidson, et al.. (1995). Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor. Arteriosclerosis Thrombosis and Vascular Biology. 15(5). 678–682. 403 indexed citations

20.

Griffing, George T., James C. Melby, Monica Holbrook, et al.. (1991). Elevated 18-Hydroxy-Corticosterone in Inbred Salt-Sensitive Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 13(3). 371–382. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact